Latest insights
News archive
Video: An overview of FDA’s premarket regulation of medical devices
FDA’s legal and regulatory framework The definition of a medical device FDA’s risk-based classification of a device...
Biopesticides, Plant Growth Regulators, and Biostimulants: 5 questions about the US regulatory framework answered
TSG Consulting recently hosted a panel discussion exploring the process of registering new products in these...
Article
April 27, 2021
Analysis of the US FDA’s draft guidance on nitinol-containing medical devices
Senior Regulatory Consultant, Dr. Om Singh, was published in the February 2020 issue of the Journal of Medical Device...
Article
February 07, 2020
BPR: 5 steps to correct substance ID
The significance of correct substance identification under the Biocidal Products Regulation (EU) No. 528/2012 (BPR) is...
Article
February 04, 2020
REACH: Brexit Q&A
Brexit is a fast-moving subject that will have regulatory and commercial implications for chemical companies with an...
Article
January 30, 2019
Professionals
Our regulatory specialists and scientists address all aspects of product registration and ongoing compliance. Read more about the individuals who make up our multi-disciplinary teams.